Jes Sanddal Lindholt is a Danish vascular surgeon, physician, author, and academic. He is a professor of Vascular Surgery and Head of the Cardiovascular Excellence Center in Region South as well as a research leader for the Department of Cardiothoracic and Vascular Surgery at the University of Southern Denmark and Odense University Hospital. He also holds the position of Adjunct Professor of Vascular Epidemiology at Aarhus University.
Lindholt's research primarily centers on epidemiology and prevention related to cardiovascular and renal failure, along with a focus on public health and translational medicine. He has contributed to more than three hundred publications, including book chapters, editorials, and review articles. He won the Odd Fellow Order researcher award in 2016.
Lindholt held a position on the Advisory Board for the National Board of Health regarding national screening programs, and the Danish Society of Vascular Surgery.
Early life and education
Lindholt earned his MD in 1990, and received his PhD from Aarhus University in 1998, with the Viborg study that led the way for adopting abdominal aortic aneurysm (AAA) screening globally, serving as the basis for his thesis. During this time, he served as a research fellow at Viborg Sygehus from 1994 to 1998 and became a Specialist in Vascular Surgery in 2003. After his education at Aarhus University Hospital and Rigshospitalet, he became a Fellow of the European Board of Vascular Surgery in 2006 and earned his medical degree in Sciences from Aarhus University in 2010.
Career
Lindholt's academic career began in 1999 as a Clinical Instructor for medical students at Viborg Hospital. From 2003 to 2012, he taught vascular surgery at Rigshospitalet and Viborg Hospital, where he held the position of Associate Professor and Consultant of Vascular Surgery from 2004 to 2012. In 2012, he took the role of Professor of Vascular Epidemiology and has been serving as a Professor of Vascular Surgery within the Department of Cardiothoracic and Vascular Surgery at the University of Southern Denmark and Odense University Hospital. Additionally, he serves as an Adjunct Professor of Vascular Epidemiology at Aarhus University.
Lindholt served as a research leader at Viborg Hospital from 2004 to 2012, and later as a member of the Research Council at Odense University Hospital from 2016 to 2022. Since 2016, he has been holding an appointment as a Research leader of the Cardiothoracic and Vascular Research Unit at Odense University Hospital and the University of Southern Denmark.
From 2008 to 2011, he co-founded the EU-FP7 project, Fighting Aneurysmal Disease (FAD) and in 2008, he assumed the role of Principal Investigator for the Viborg Vascular Screening Trial (VIVA), contributing to advances in vascular screening. In 2013, he co-founded the Elite Research Center of Individualized Medicine in Arterial Disease (CIMA) and became the PI for the Danish Cardiovascular Screening Trial (DANCAVAS) in 2014. He also served as the chairman for the Vascular Specialist Council of Southern Denmark in 2015 to 2023 and Clinical Cardiovascular Centre of Excellence (CAVAC) in 2016 to 2020. In 2022, he coordinated both the EU-Horizon2020 project TELEGRAFT and the Innovation Fund Grand Solution project PREPARE.
Media exposure
Lindholt has been a frequent guest in various media outlets, discussing his cardiovascular screening studies and their impact on preventing deaths. He appeared on TV Syd to discuss The DANCAVAS studies involving cardiovascular screening of 15,000 men in the Southern Denmark Region. He also featured on TV Midtvest, highlighting the importance of screening programs and the prevalence of undiagnosed cardiovascular diseases. On TV 2, he underscored the impact of the VIVA screening program, stating that it reduces mortality in 65-74 year old men by up to seven percent and on DR TV, he advocated for screening for Abdominal Aortic Aneurysms in a documentary produced by Peter Q. Geisling. Additionally, he discussed his computer-based program for predicting cardiovascular disease risk (PREPARE) in Fyens Stiftstidende and P4, emphasizing its potential to detect and prevent nearly half of the cases by homebased risk assessment using artificial intelligence.
Research
Lindholt is most known for his research in cardiovascular epidemiology, public health, abdominal aortic aneurysms and translational medicine, with a specific focus on screening and prevention, biomarkers, medical treatment of aneurysms, aortic dissection and rupture. In recent years, his work has provided insights into lower limb atherosclerosis, stemming from preventive population studies conducted at VIVA and DANCAVAS.